Table 3.
HR [95 % CI]a | ||||
---|---|---|---|---|
No fatty liver—no fatty liver (reference group) (n = 1344) | Fatty liver—no fatty liver(resolved fatty liver) (n = 112) | No fatty liver—fatty liver (incident fatty liver) (n = 251) | Fatty liver—fatty liver (persisting fatty liver) (n = 382) | |
Model 1 | 1 | 3.05 [1.47–6.36] | 5.34 [3.29–8.65] | 7.34 [4.77–11.28] |
Model 2 | 1 | 3.10 [1.48–6.47] | 5.31 [3.27–8.63] | 7.42 [4.80–11.47] |
Model 3 | 1 | 1.29 [0.60–2.80] | 3.31 [1.99–5.51] | 2.60 [1.61–4.20] |
Model 1: adjusted for age and sex; model 2: adjusted for model 1 plus alcohol, smoking status, and exercise; model 3: adjusted for model 2 plus glucose, waist circumference, systolic blood pressure, triglyceride, and HDL-C
aLogistic regression was used to determine hazard ratio (HR) for developing metabolic syndrome at follow-up